Monoclonal gammopathy of undetermined significance

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is monoclonal gammopathy of undetermined significance?

Monoclonal gammopathy of undetermined significance is a condition in which a paraprotein is found in the blood during standard laboratory tests. MGUS usually is asymptomatic, but peripheral neuropathy can occur.

Common symptoms reported by people with monoclonal gammopathy of undetermined significance

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with monoclonal gammopathy of undetermined significance

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Ultram)
Type
Prescription Drug
How many have tried
3
Tried for
pain (3)
Treatment name(s)
Type
Procedures
How many have tried
2
Treatment name(s)

(Albuterol Inhaler)
Type
Prescription Drug
How many have tried
1
Tried for
fatigue (1)
Treatment name(s)

(Elavil)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(Valium)
Type
Prescription Drug
How many have tried
1
Tried for
anxious mood (1)
Treatment name(s)

(Cymbalta)
Type
Prescription Drug
How many have tried
1
Tried for
depressed mood (1)
Treatment name(s)

(Norco)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(Gammaglobulin (IVIg))
Type
Prescription Drug
How many have tried
1
Treatment name(s)
Type
Complementary and Alternative Medicine
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(Pamelor)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)

Data from patients with monoclonal gammopathy of undetermined significance, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with monoclonal gammopathy of undetermined significance

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Ultram)
Perceived effectiveness
for pain (3 evaluations)
Side effects
tired for a few hours after treatment
Total evaluations
3
Tried for
pain (3)
Treatment name(s)
Perceived effectiveness
for monoclonal gammopathy of undetermined significance (2 evaluations)
Side effects
Hospitalization muscle soreness
Total evaluations
2
Treatment name(s)

(Albuterol Inhaler)
Perceived effectiveness
for fatigue (2 evaluations)
Side effects
jumpiness (startling easily)
Total evaluations
2
Tried for
fatigue (1)
Treatment name(s)

(Elavil)
Perceived effectiveness
for pain (1 evaluation)
Side effects
dry mouth tiredness
Total evaluations
2
Tried for
pain (1)
Treatment name(s)

(Valium)
Perceived effectiveness
for anxious mood (1 evaluation)
Side effects
increased sleepiness
Total evaluations
1
Tried for
anxious mood (1)
Treatment name(s)

(Cymbalta)
Perceived effectiveness
for depressed mood (2 evaluations)
Side effects
tiredness
Total evaluations
2
Tried for
depressed mood (1)
Treatment name(s)

(Norco)
Perceived effectiveness
for pain (1 evaluation)
Side effects
drowsiness
Total evaluations
1
Tried for
pain (1)
Treatment name(s)

(Gammaglobulin (IVIg))
Perceived effectiveness
for monoclonal gammopathy of undetermined significance (4 evaluations)
Side effects
headaches
Total evaluations
4
Treatment name(s)
Perceived effectiveness
for pain (1 evaluation)
Side effects
Total evaluations
1
Tried for
pain (1)
Treatment name(s)

(Pamelor)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
pain (1)
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with monoclonal gammopathy of undetermined significance, who reported starting treatments within the last 5 years.
Last updated:

Who has monoclonal gammopathy of undetermined significance on PatientsLikeMe?


Age
Age Proportion # of patients
<20 1
20s 0
30s 5
40s 31
50s 79
60s 80
70+ 47
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 1
20-29 years 0
30-39 years 10
40-49 years 18
50-59 years 18
60-69 years 13
70+ years 0

Distribution of sex

Sex
Sex Proportion # of patients
Male 53
Female 194

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 110
Not Diagnosed 3

These charts show data from MGUS patients who have completed their condition history
Last updated: